Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)

Clinical trial NCT04941261 · UNKNOWN

Trial details

NCT number: NCT04941261
Sponsor: National Vaccine and Serum Institute, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Norovirus Infections Norwalk Gastroenteritis

Start date: 2021-06-30
Primary completion: 2024-02-28
Enrollment: 1716

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.